Guanidinium‐Stapled Helical Peptides for Targeting Protein‐Protein Interactions
Abstract Peptide stapling has emerged as a versatile approach in drug discovery to reinforce secondary structure elements especially α‐helices and improve properties of linear bioactive peptides. Inspired by the prevalence of arginine in protein‐protein and protein‐DNA interfaces, we investigated guanidinium‐stapling as a means to constrain helical peptides. Guanidinium stapling was readily achieved on solid support, utilizing two orthogonally protected lysine or unatural α‐amino acid residues with an amino function. This method allows for easy modulation of the nature and size of the staple as well as helix propensity. Evaluating a set of guanidinium‐stapled peptides for their interaction with different protein targets identified several binders with increased target affinity. X‐ray structure determination of four complexes revealed that all stapled peptides adopt a helical conformation upon protein binding. Notably, the disubstituted guanidinium generally exhibits a distinct cis / trans conformation and, in one instance, retains a conserved hydrogen bond with the protein surface. By identifying, for the first time, the guanidinium moiety as an effective helical peptide stapling group, this research significantly expands the repertoire of α‐helix stapling techniques for the creation of useful protein mimics.
Authors
- Carole Peluso‐Iltis
- Maxime Neuville
- Camille Perdriau
- Natacha Rochel (ORCID: https://orcid.org/0000-0002-3573-5889)
- Katharina Zimmeter (ORCID: https://orcid.org/0009-0000-2289-8091)
- Morgane Pasco (ORCID: https://orcid.org/0000-0002-1556-2802)
- Gavin W. Collie (ORCID: https://orcid.org/0000-0002-0406-922X)
- Gilles Guichard (ORCID: https://orcid.org/0000-0002-2584-7502)
- Judit Ősz
- Brice Kauffmann (ORCID: https://orcid.org/0000-0002-2932-3255)
- Claire Saragaglia (ORCID: https://orcid.org/0000-0002-9686-8992)
- Anaïs Luton
Institutions
- AstraZeneca (United Kingdom) (GB)
- Centre National de la Recherche Scientifique (FR)
- Université de Bordeaux (FR)
- Inserm (FR)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- AstraZeneca (Singapore) (SG)
- Chimie et Biologie des Membranes et des Nanoobjects (FR)
- Institut Européen de Chimie et Biologie (FR)
- AstraZeneca (Germany) (DE)
- Institut Polytechnique de Bordeaux (FR)
Publication Details
- Journal
- Angewandte Chemie
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1002/ange.202416348
- Primary Topic
- Chemical Synthesis and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Association Nationale de la Recherche et de la Technologie
- Centre National de la Recherche Scientifique
- Conseil Régional Aquitaine